SONX · Sonendo, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $8.04M | $8.31M | $7.05M | - | $10.41M | $11.04M | $10.72M | - | $9.85M |
| Cost of Revenue | - | $4.73M | $9.25M | $5.05M | - | $7.96M | $9.95M | $7.38M | - | $7.53M |
| Gross Profit | - | $3.31M | $3.12M | $2.00M | - | $2.45M | $1.10M | $3.35M | - | $2.32M |
| R&D | - | $1.59M | $1.57M | $2.19M | - | $3.05M | $3.30M | $3.49M | - | $4.33M |
| SG&A | - | $7.71M | $6.42M | $10.06M | - | $13.44M | $14.75M | $14.67M | - | $12.59M |
| Total Operating Expenses | - | $10.10M | $9.80M | $12.25M | - | $18.54M | $18.05M | $18.16M | - | $16.91M |
| D&A | - | - | - | $64.0K | - | - | - | $339.0K | - | - |
| Operating Income | - | ($6.79M) | ($6.69M) | ($10.25M) | - | ($16.10M) | ($16.95M) | ($14.81M) | - | ($14.60M) |
| Interest Expense | - | $1.01M | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | ($7.54M) | ($7.37M) | ($6.76M) | - | ($16.98M) | ($17.69M) | ($15.37M) | - | ($15.54M) |
| EPS - Basic | - | ($15.77) | ($3200.00) | ($2800.00) | - | ($7200.00) | ($7600.00) | ($6400.00) | - | ($18800.00) |
| EPS - Diluted | - | ($15.77) | ($3200.00) | ($2800.00) | - | ($7200.00) | ($7600.00) | ($6400.00) | - | ($18800.00) |
Balance Sheet
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.23M | $13.10M | $15.70M | $18.58M | $14.01M | $12.09M | $12.57M | $12.65M | $17.66M | $68.51M |
| Accounts Receivable | $3.68M | $4.45M | $4.53M | $4.18M | $5.08M | $5.60M | $6.31M | $6.43M | $5.80M | $3.35M |
| Inventory | $10.21M | $11.49M | $11.80M | $12.12M | $11.07M | $11.44M | $13.16M | $15.97M | $15.46M | $15.19M |
| Accounts Payable | $1.96M | $686.0K | $931.0K | $916.0K | $1.18M | $950.0K | $1.09M | $5.39M | $4.44M | $2.06M |
| Current Assets | $27.80M | $34.72M | $42.51M | $52.65M | $65.27M | $75.49M | $87.21M | $106.44M | $121.11M | $127.03M |
| Total Assets | $31.27M | $38.13M | $46.30M | $56.77M | $78.16M | $88.33M | $104.14M | $123.91M | $137.28M | $142.94M |
| Current Liabilities | $19.94M | $19.11M | $17.73M | $18.95M | $35.32M | $11.05M | $11.35M | $15.23M | $16.72M | $14.35M |
| Long-term Debt | $3.64M | $6.08M | $8.51M | $10.91M | $12.47M | $37.20M | $37.04M | $36.89M | $36.75M | $36.60M |
| Total Liabilities | $26.07M | $27.16M | $28.43M | $32.24M | $49.74M | $50.55M | $51.09M | $55.33M | $55.33M | $52.58M |
| Stockholders' Equity | $5.19M | $10.97M | $17.87M | $24.53M | $28.42M | $37.78M | $53.04M | $68.58M | $81.95M | $90.36M |
| Retained Earnings | ($458.05M) | ($451.68M) | ($444.14M) | ($436.77M) | ($430.01M) | ($419.13M) | ($402.15M) | ($384.46M) | ($369.09M) | ($358.24M) |
Cash Flow
| Line item | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($10.69M) | - | - | - | ($16.98M) | - | - |
| Investing Cash Flow | - | - | - | $32.07M | - | - | - | $11.96M | - | - |
| Financing Cash Flow | - | - | - | ($16.81M) | - | - | - | ($6.0K) | - | - |
| CapEx | - | - | - | $146.0K | - | - | - | $210.0K | - | - |
| Free Cash Flow | - | - | - | ($10.84M) | - | - | - | ($17.19M) | - | - |
Ratios
| Metric | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 41.2% | 37.5% | 28.4% | - | 23.5% | 9.9% | 31.2% | - | 23.5% |
| Operating margin | - | -84.5% | -80.4% | -145.4% | - | -154.7% | -153.5% | -138.1% | - | -148.2% |
| EBITDA margin | - | - | - | -144.5% | - | - | - | -135.0% | - | - |
| Net margin | - | -93.8% | -88.6% | -96.0% | - | -163.2% | -160.2% | -143.3% | - | -157.8% |
| Free cash flow margin | - | - | - | -153.8% | - | - | - | -160.3% | - | - |
| FCF / Net income | - | - | - | 1.60 | - | - | - | 1.12 | - | - |
| R&D / Revenue | - | 19.8% | 18.9% | 31.1% | - | 29.3% | 29.9% | 32.6% | - | 44.0% |
| SG&A / Revenue | - | 95.9% | 77.2% | 142.8% | - | 129.2% | 133.6% | 136.8% | - | 127.8% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | -19.8% | -15.9% | -11.9% | - | -19.2% | -17.0% | -12.4% | - | -10.9% |
| Return on equity | - | -68.7% | -41.2% | -27.6% | - | -44.9% | -33.3% | -22.4% | - | -17.2% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.39 | 1.82 | 2.40 | 2.78 | 1.85 | 6.83 | 7.69 | 6.99 | 7.24 | 8.86 |
| Quick ratio | 0.88 | 1.22 | 1.73 | 2.14 | 1.53 | 5.80 | 6.53 | 5.94 | 6.32 | 7.80 |
| Cash ratio | 0.51 | 0.69 | 0.89 | 0.98 | 0.40 | 1.09 | 1.11 | 0.83 | 1.06 | 4.78 |
| Leverage | ||||||||||
| Debt / Equity | 0.70 | 0.55 | 0.48 | 0.44 | 0.44 | 0.98 | 0.70 | 0.54 | 0.45 | 0.41 |
| Debt / Assets | 0.12 | 0.16 | 0.18 | 0.19 | 0.16 | 0.42 | 0.36 | 0.30 | 0.27 | 0.26 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | -6.7x | - | - | - | - | - | - | - | - |
| Equity multiplier | 6.02 | 3.48 | 2.59 | 2.31 | 2.75 | 2.34 | 1.96 | 1.81 | 1.68 | 1.58 |
| Liabilities / Assets | 0.83 | 0.71 | 0.61 | 0.57 | 0.64 | 0.57 | 0.49 | 0.45 | 0.40 | 0.37 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.21 | 0.18 | 0.12 | - | 0.12 | 0.11 | 0.09 | - | 0.07 |
| Inventory turnover | - | 0.41 | 0.78 | 0.42 | - | 0.70 | 0.76 | 0.46 | - | 0.50 |
| Days sales outstanding | - | 202d | 199d | 216d | - | 196d | 208d | 219d | - | 124d |
| Days inventory outstanding | - | 887d | 466d | 876d | - | 525d | 483d | 790d | - | 736d |
| Days payable outstanding | - | 53d | 37d | 66d | - | 44d | 40d | 267d | - | 100d |
| Cash conversion cycle | - | 1036d | 628d | 1026d | - | 678d | 651d | 742d | - | 761d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | 0.4x | 72.6x | 81.9x | - | 372.3x | 480.4x | 154.0x | - | 78.4x |
| P / S | - | 0.5x | 156.1x | 285.1x | - | 1351.5x | 2307.5x | 984.9x | - | 719.8x |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | -22.8% | -24.7% | -34.3% | - | 5.7% | 4.7% | 18.7% | - | 24.8% |
| Revenue CAGR (3y) | - | 0.6% | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | 35.3% | 183.8% | -40.2% | - | 5.5% | -47.5% | 46.8% | - | 93.0% |
| Operating income growth (YoY) | - | 57.8% | 60.6% | 30.8% | - | -10.3% | -18.6% | -50.5% | - | -31.5% |
| Net income growth (YoY) | - | 55.6% | 58.4% | 56.0% | - | -9.3% | -16.9% | 1.0% | - | -22.0% |
| EPS growth (YoY) | - | 99.8% | 57.9% | 56.3% | - | 61.7% | -82869.4% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | 37.0% | - | - | - | -30.8% | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -81.7% | -71.0% | -66.3% | -64.2% | -65.3% | -58.2% | 17.8% | 17.9% | 13.7% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Product / service
$30.25M totalProduct$30.25M · 100.0%
Peer comparison
Same SIC group: Dental Equipment & Supplies
Comparing Sonendo against the 5 most active filers in the same SIC group.